Psyched Wellness Ltd. Provides Update on Pre-Clinical Trial of its Muscimol Extract AME-1
March 02, 2021 at 07:54 am EST
Psyched Wellness Ltd. announced the company has received the results from its Maximum Tolerated Dosage (MTD) study conducted by KGK Science, a licensed CRO in Canada. This study is the first set of thorough toxicology assessments on the company's Amanita Muscaria extract, AME-1. The MTD study summarizes the maximum tolerated dose and LD50 thresholds for AME-1. This significant set of information obtained permits for the next step of pre-clinical studies involving a 14- and 90-day oral toxicity to further identify a safe, effective dose for human consumption.